Previous close | 20.55 |
Open | 20.82 |
Bid | 20.85 x 100 |
Ask | 20.95 x 100 |
Day's range | 20.55 - 20.98 |
52-week range | 18.91 - 30.68 |
Volume | |
Avg. volume | 166,629 |
Market cap | 632.898M |
Beta (5Y monthly) | 1.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | -5.47 |
Earnings date | 01 Nov 2024 - 05 Nov 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 27.67 |
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...
Fulgent Genetics (FLGT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The mean of analysts' price targets for Fulgent Genetics (FLGT) points to a 27.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.